About the CPD course
The Decentralised Procedure is one of three routes available to applicants to gain multinational marketing authorisation for a medicinal product within the European Economic Area (EEA) on the basis of a single application. It can be used only for a product which has no existing marketing authorisation in any member state. This module describes the roles of the various players in the procedure; the sequence and duration of the stages involved; and the requirements on content; format and timing of submissions. It discusses the special issues that apply to generic products in the DCP.
Send an enquiry
grapl
grapl is a UK based digital learning and development specialist, authoring and designing Zenosis® courses to provide an extensive eLearning library for the pharmaceutical, biotech and medicinal products sector. This learning can be delivered via the customers LMS, the grapl LMS or its social, knowledge and collaborative CloudRooms platform. Continuously updated to reflect regulatory changes, Zenosis® courses are trusted to educate their people by some of the worlds leading companies.
Want to learn more?
More CPD courses by grapl
Education
An Introduction to Drug Safety and Pharmacovigilan...
grapl
Drug safety monitoring and risk management are vitally important for medicinal product developers; l...
Online Course
Education
An Introduction to Clinical Trials and Drug Develo...
grapl
This course provides an understanding of how clinical trials fit into the drug development process....
Online Course
Education
An Introduction to Clinical Trial Preparation and...
grapl
Worldwide expenditure on R&D by the pharmaceutical industry is continually increasing. Most of the f...
Online Course
Education
ICH Good Clinical Practice
grapl
Good Clinical Practice (GCP) is a set of internationally recognised ethical and scientific quality r...
Online Course
Get industry-related content straight to your inbox
Thank you for subscribing
By signing up to our site you are agreeing to our privacy policy